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Summary
A mutant strain (LEC) of rats was found to have a novel defect in T cell maturation, that is,
arrest of differentiation from CD4+8+ to CD4+8 - but not to CD4 - 8+ thymocytes. FACS
analyses demonstrated a deficiency in the CD4+8- T cell subset in the thymus and a marked
decrease in CD4+ T cells in peripheral lymphoid organs. Expression of the T cell receptor
(TCR)/CD3 complex in CD4+8+ and CD4 - 8+ thymocytes of LEC rats was normal. Ex-
pression of class II major histocompatibility complex (MHC) in the thymus of LEC rats was
also the same as that of normal rats. These results indicate that maturational arrest occurs only
in the transition pathway from CD4+8+ to CD4+8 - thymocytes, and that this mutation can
not be attributed to the default of expression ofeither TCR/CD3, CD4, or class II MHC antigen.
Consequently, dysfunction of helper T cells was observed in LEC rats, while killer T cells and
B cellsfunctioned normally. Although the complete identification of the origin of this mutation
requires further studies, it is hoped that such investigations will throw light on the mechanism
of positive selection.
P
reT cells differentiate into mature T cells in the thymus.
During this process, potentially autoreactive thymocytes
are clonally eliminated (negative selection) (1-4), whileother
thymocytes receive differentiative signals by interacting with
thymic stromal cells (positive selection) (5, 6). The positive
selection hypothesis is supported by the alteration of MHC
restriction from the donor type to be recipient type in bone
marrow chimera mice, and also by the alteration of surface
marker antigens (CD4 and CD8) expressed on thymocytes
from double-positive (CD4+8+) to single-positive (either
CD4+8- or CD4-8+) phenotypes. The interaction between
MHC and either TCR, CD4, or CD8 antigen molecules has
been shown to be a prerequisite for the differentiation of
CD4+8+ into either CD4+8- or CD4 - 8+ cells (7-17).
Thus, administration ofantiTCR antibody to neonatal mice
blocks the appearance of matured T cells (12), and adminis-
tration of either anti-class II MHC or CD4 antibody to
neonatal mice or thymus in organ culture blocks the differ-
entiation of CD4+8+ cells to CD4+8- cells (10, 11, 16).
Moreover, administration ofeither anti-classI MHC or CD8
antibody to neonatal mice blocks differentiation to CD4 '8+
cells (7-9, 17). However, the molecular mechanism of posi-
tive selection is unknown.
We report here a novel mutant rat (LEC) in which differen-
tiation from CD4+8+ to CD4+8 - cells in the thymus is
blocked genetically but differentiation to CD4 - 8+ cells is
normal. This is the first report of an animal model with a
genetic block at the specific stage in T cell differentiation.
Although the origin of this mutation is still unknown, this
mutant should be useful in studies on the mechanism ofposi-
tive selection in the thymus.
Materials and Methods
Rats.
￿
LEC/Tj, LEA/Tj, and ACI/Tj rats were maintained in
our laboratory in specific pathogen-free (SPF)' conditions. LEC
rats were originallyestablished at the Center for Experimental Plants
and Animals (Hokkaido University, Japan) (18). SPF LEC rats were
provided by Otsuka Pharmaceutical Co. Ltd. (Tokushima, Toku-
shima, Japan). WKAH/Slc rats were purchased from Shizuoka Lab-
oratory Animal Center (Hamamatsu, Shizuoka, Japan).
AntibodiesandReagents.
￿
Anti-rat class II MHC mAb, OX6 (19),
ascites was a gift from Dr. H. Kimura, University ofPennsylvania
(Philadelphia, PA). The anti-rat TCRa/O mAb, R73 (20), hy-
bridoma cell line was a gift fromDr. T Htinig, Universitat Wurz-
burg (W(irzburg, FRG). Anti-rat CD4 mAb, W3/25 (21), and
anti-rat CD8 mAb, OX8 (22),hybridoma cell lines were gifts from
'Abbreviation used in this paper. SFF, specific pathogen-free.
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1615-1624Dr.M. Miyasaka, Tokyo Metropolitan InstituteforMedical Sciences
(Tokyo, Japan). Anti-rat CD3 mAb, 1F4 (23), ascites was a gift
from Dr.YHashimoto, Tohoku University (Sendai,Japan). Purified
antibodies were labeled with FITC or PE by standard procedures.
AVectastain ABC kit andbiotinylated anti-mouse IgG and IgM
were purchasedfrom Vector Laboratories, Inc. (Burlingame, CA).
AcDNA cloneencoding murine 114, 2AE3 (24), was agift from
DNAX Research InstituteofMolecular andCellular Biology (Palo
Alto, CA). Other reagents were obtained from the following
sources: RPMI 1640, FCS, penicillin, streptomycin, and gentamicin
(Gibco Laboratories, GrandIsland,NY); PE, mitomycinC, methyl
ot-D-mannopyranoside,MEMnonessential aminoacid,ConA, and
PWM (Sigma Chemical Co., St. Louis, MO); streptavidin Duo-
CHROM and FACS Lysing Solution (Becton Dickinson & Co.,
Mountain View, CA); murine rIL2 andrIL4 (Genzyme, Boston,
MA); Nu-Serum (Collaborative Research Inc., Lexington, MA);
Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ);DMEM
(Nissui Pharmaceutical Co. Ltd., Tokyo, Japan); SRBC (Nippon
BioTest Labs. Inc., Kokubunji, Tokyo, Japan); DNP-aminoeth-
ylcarboxymethyl-Ficoll (Biosearch, San Rafael, CA); paraform-
aldehyde (Nacalai Tesque Inc., Kyoto, Japan); ['2P]deoxyCTP
(Amersham International, Amersham, UK); [5'Cr] sodium chro-
mate (New England Nuclear, Boston, MA).
FACSAnalyses.
￿
Thymocytes were prepared from rats (4-6 wk
old) and stained with both FITC-conjugated anti-CD4 and PE-
conjugated anti-CD8 mAbs for two-colorstaining. Forthree-color
staining, Thmocytes were first incubatedwith anti-TCR or anti-
CD3 mAb, and then with biotinylated anti-mouse IgG for anti-
TCRor biotinylated anti-mouse IgM foranti-CD3.Thefree arms
ofbiotinylated anti-mouseIg antibodies were blockedwith mouse
Ig, and then streptavidin DuoCHROM, FITC-conjugated anti-
CD4, andPE-conjugated anti-CD8 mAbs were added.Lymphnode
cells were prepared from mesenteric lymph nodes and stained by
either the one-color or three-color staining procedure described
above. Spleen cells were stained with FITC-conjugated anti-CD4
or FITC-conjugated anti-CD8 mAb. Stained cells were fixed in
0.1% paraformaldehyde/saline. Bloodcellswere treated with FACS
lysing solution after staining with either FITC-conjugated anti-
CD4 or anti-CD8 mAb. Analyses were performed with a FAC-
Scan andeither aConsort30 or FACScansoftwareprogram(Becton
Dickinson & Co.). Dead cellswere gatedoutby forward and side
light scatters.
Immunohistochemist7
￿
Frozen thymuses from 5-wk-old rats were
sectionedin 6-pm thickness, andsections were stained with hema-
toxylin andeosin. Adjacent sections were incubatedwith anti-rat
class II MHC mAb, and then with biotinylated anti-mouse IgG
and thecomplex ofavidin andbiotinylated peroxidase (Vectastain
ABC kit). Afterincubating with 0.02% 3-3'-diaminobenzidinein
0.1 M Tris-HC1(pH 7.6) at room temperature for 5 min, thesec-
tions were counter-stained with methylgreen.
CTLAssay.
￿
Mesenteric lymphnode cells(responder cells) were
prepared from LEC (RT1°) or LEA (RT1°) rats, and 5 x 106/ml
cells were cocultured for 5 d with 2.5 x 106/rnl ACI spleen cells
(RT1') that hadbeen treated with 30 ltg/ml mitomycin C for 40
minat 37°C. Theculture medium (5 ml)wasDMEM supplemented
with 5% FCS, 10% Nu-Serum, 10 mM Hepes, 5.5 mM gluta-
mine, 0.16 MM. r,-asparagine, 0.55 MM r.-arginine-HCI, 1x MEM
nonessential amino acid, 50 ;LM 2-ME, 100 U/ml penicillin, 100
Rg/mlstreptomycin, and0.5 mg/mlgentamicin. Afterculture, the
cells were harvested and suspended in i ml of the same medium.
Con A blast cells were prepared by culturing ACI rat spleen
cells with 2.5 hg/mlConAfor2 d. TheseConAblast cells were
enriched by Ficoll-Paque density gradient centrifugation (1,500 g,
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for 15 min), washed with 2% methyl a-D-mannopyranoside, and
labeled with "Cr by incubating 10' cells with 200 p.Ci [5'Cr]so-
dium chromate for 2 h at 37°C.
An aliquot of theeffector cell suspension (100 pl) wasincubated
with [5'Cr]-labeled target cells (105 cells) for 15 h at 37°C in
a total volume of 200 pl of DMEM. The mixture was then
centrifuged at 1,500g for 10 min, and 150 pl of the supernatant
was removed for measurement of radioactivity. The cytolytic ac-
tivity was expressed as specific killingcalculated as: 100x (a -b)/
(t - b); wherea is the"Cr release in the presence of effector cells,
bis spontaneous releasefrom labeled target cellsin the absenceof
effector cells, andtis thetotalradioactivity releasableby incubating
with 0.1% NP40.
Cytokine Assay. Lymphocytes (5 x 106 cells/ml) prepared
from spleen and mesenteric lymph nodes of rats of 4-6 wk old
were cultured in the presence of 2.5 ug/ml Con A or 5 Wg/ml
PWM for2d. Theculture medium was RPMI 1640 supplemented
with 10% FCS, 1 mM sodium pyruvate, 50 PM 2-ME, 100U/ml
penicillin, and 100 Fbg/ml streptomycin. After stimulation by
mitogens, the culture supernatant was collected, diluted serially
with freshculture medium, and added to cultures of CTLL2cells
(50% [vol/vol]). Murine rIL2 and rIL4 were also serially diluted,
from an initial concentration of 1,000U/ml, andadded to thecul-
ture system (50% [vol/vol]). CTLL2 cells (5 x 10'/well) were
cultured for 2 d. The proliferation of CTLL2 cells was assayed
colorimetrically as described previously (25).
Detection of tnRNAfor Rr4.
￿
Mitogen-stimulated spleen cells
were collected, andtheRNAfraction wasprepared from theguani-
dine thiocyanate (5.5 M) extracts by cesium chloride (5 M) density
gradient centrifugation, as describedpreviously (26), with slight
modifications. A sample of 10 wg of RNA fraction was treated
with formaldehyde, subjected to 1% agarose gel electrophoresis,
and then transferred to a nitrocellulose membrane. A Pst-I frag-
ment (360 bp) for murine IL4 cDNA was labeled with [32P]de-
oxyCTP, as describedpreviously (27) (specific radioactivity, 2 x
108 dpm/pg), and used as a probe for hybridization. Hybridiza-
tion wasperformedovernight at 42°C in asolution of0.1 MPipes-
NaOH (pH6.8), 50% formamide, 0.65 M NaCI, 5x Denhardt's
solution (0.1%BSA, 0.1% polyvinylpyrrolidone, and0.1%Ficoll),
0.1% SDS, 5 mM EDTA, and 100 kg/ml sonicated salmon sperm
DNA. Themembrane waswashed four timesat 50°C with asolu-
tion of2x SSCcontaining 0.2% sodium pyrophosphateand0.1%
SDS, andwas exposedto XAR5 X-rayfilm (Eastman Kodak Co.,
Rochester, NY) overnight.
PlaqueformingAssay.
￿
Rats were immunized intraperitoneally
with SRBC (2 x 108) or DNP-conjugated Ficoll (50 Rg). After
5 d, plaque-forming spleen cells were estimatedby the method of
Jerne and Nordin (28). SRBC and TNP-conjugated SRBC were
used as target cellsforrats that had been immunizedwith SRBC
and DNP-conjugated Ficoll, respectively.
Results and Discussion
Deficiency in CD4' TCells.
￿
An LEC (Long-Evans with
a cinnamon-like coat color) rat was obtained by a sponta-
neous mutation at the 24th generation during inbreeding and
wasoriginally reported to developspontaneous hepatitis and
hepatocarcinoma(18, 29). However, we foundseveral abnor-
malities in thelymphoid system ofthis rat, such as areduced
level of serum IgG (30), hypoplasia of the thymus and the
spleen, and hypoplasia of the medulla in the thymus. Thus,
we examined thedistribution ofT cell subsetsin thethymusB
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by FACS analyses using anti-CD4 and -CD8 mAbs (Fig. 1
A and Table 1). In the cell population from normal rat
(WKAH) thymus, most of the thymocytes (76%) express
both CD4 and CD8 antigens (CD4+8+ cells), with smaller
numbers of CD4 single-positive cells (CD4+8', 15%),
CD8 single-positive cells (CD4 - 8+, 5.5%), and double-
negative cells (CD4-8- , 3.5%). In contrast, the thymus of
LEC rats contains scarcely any CD4+8_ cells (<1%). How-
ever, no significant differences were observed in the percen-
tages of CD4-8+ and CD4 -8 - cells in WKAH and LEC
rats. The percentage ofdouble-positive cells was 12% higher
in LEC rats than in WKAH rats; this increase seemed to
correspond to the percentage of disappearance of CD4+8'
cells. These results indicate that LEC rats are defective in the
transition pathway from CD4+8+ to CD4+8- cells.
We also examined the distribution of T cell subsets in pe-
ripheral lymphoid organs of the two strains. As shown in
Fig. 1 B and Table 1, 'the most striking finding was that the
percentages of CD4+ cells in three kinds ofperipheral lym-
phoid organs were much lower in LEC rats than in WKAH
rats. CD4 antigen was expressed by one quarter of the spleen
cells in WKAH rats but by only 5% of those in LEC rats.
Since the anti-rat CD4 mAb (W3/25) crossreacts with mac-
rophages (31), the actual percentage of CD4-bearing T cells
in LEC rats seems to be marginal. Although the percentage
of CD8+ spleen cells was slightly lower in LEC rats than
that in WKAH rats, no significant difference was observed.
The lymph nodes of LEC rats contained a relatively large
number of CD4+ cells (20%), but the percentage of CD4+
cells was much lowerthan that in WKAH rats. On the other
Fluorescence Intensity
Figure 1.
￿
FACS analyses of CD4/CD8 antigens on thymocytes (A) and CD4 antigen on spleen, lymph node, and PBL (B).
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than that in WKAH rats, but this seemed to indicate an ap-
parent increase with a decrease in the number of CD4+ cells
on FRCS analysis, and did not mean an increase in the abso-
lute number of CD8+ cells. Results for peripheral blood
cells were similar to those for spleen cells. These results are
consistent with the observation ofdeficiencyin mature CD4-
bearing T cells in the thymus of LEC rats.
The CD4/CD8 phenotype of Tymocytes and peripheral
lymphocytes of Ft offsprings from LEC and WKAH rats
were analyzed (Table 1). The data for Fi rats were similar
to those for WKAH rats. Furthermore, backcrossed progeny
of (WKAH x LEC)Fj and LEC showed a 1:1-segregated
phenotype in terms of deficiency in CD4+ T cells in the pe-
ripheral blood (T. Yamada, T Natori, K. Izumi, T Sakai,
T Agui, and K. Matsumoto,manuscript submitted for pub-
lication). These data suggest that this mutation is caused by
a single recessive gene.
TCR/CD3 Expression.
￿
Interaction between TCR and class
II MHC has been shown to be necessary for maturation from
CD4+8+ to CD4+8 - cells (12-15). Therefore, we examined
the expression ofTCR/CD3 antigens in each subset of thymo-
cytes (Fig. 2, A and B). The most important finding was
that the TCR/CD3 antigen complex was expressed on
CD4+8+ cells in LEC rat thymus. In LEC thymus, 49.1 ±
11.1% (mean ± SEM; three to four rats) of the CD4+8+
cells were TCRa/o' , and 50.9 ± 11.1% were dull-
positive; these values were similar to those in WKAH rat
thymus (50.3 ± 4.4% for negative and 49.7 t 4.4% for
dull-positive). A second notable finding was that both TCR
a//3 and CD3 antigens were brightly positive in -40% of
the CD4' 8+ cells in LEC rat thymus (31.2 ± 2.8% for
TCRa/o and 41.5 ± 1.1% for CD3), as well as in WKAH
rat thymus (40.8 t 2.8% for TCRa/S and 45.0 ± 5.8%
for CD3). This indicates that differentiation from CD4+8+
to CD4 - 8+ cells is normal in LEC rat thymus. A third
finding was that the ratio of TCR/CD3+ cells in the
1618
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CD4- 8- subset was less in LEC rat thymus than that in
WKAH rat thymus (5 .9 ± 0.3% vs. 23.3 ± 4.3% for TCR
a/0 and 12.7 ± 0.4% vs. 33.9 ± 3.6% for CD3). The differ-
ence between the percentages of CD3+ cells and TCRa/(3+
cells can be regarded as that of TCR-y/b+ cells, despite the
absence of direct evidence for this using anti-rat TCR,y/S
antibody. The results, therefore, indicate that the ratio of ma-
tured CD4' 8- cells (both TCRa/S+ and -.y/S+) is less in
LEC rats than in WKAH rats. However, it is unclear whether
this is related to the defect in maturation from CD4+8+ to
CD4+8- cells.
Class II MHCExpression.
￿
Since CD4 and TCR/CD3 an-
tigens are expressed on CD4+8+ cells in LEC rats, it might
be supposed that class II MHC antigen is not expressed in
the thymus. However, as shown in Fig. 3, class II MHC an-
tigen is expressed in the thymus (both the cortex and medulla)
of LEC rats as in WKAH rats, in spite of hypoplasia of the
medulla. Furthermore, the data for backcrosses between ei-
ther (WKAH x LEC)F, or (BN x LEC)F, and LEC rats
showed no hereditary linkage between deficiency in CD4+
T cells and the MHC haplotype (T. Yamada et al., manu-
script submitted for publication). These data indicate that
this mutation is not a mutation of the class II MHC gene.
Normal Maturation ofCD8+ T Cells.
￿
The percentage of
CD8+ cells was normal in the peripheral lymphoid organs
of LEC rats (Fig. 1 and Table 1) . Expression of TCR/CD3
antigens by CD4-8+ subset cells in the thymus was also
normal (Fig. 2). We further examined both TCR/CD3 ex-
pression and the function of peripheral CD8+ T cells to
confirm that the one side of maturational pathway of T cells
(maturation of CD8+ T cells) is normal in LEC rats. As
shown in Fig. 4, most of the CD8+ lymph node cells were
CD3+ (93.7 ± 3.7%, mean ± SEM; three to four rats);
further, 66.6 ± 5.8% of the CD8+ cells were also TCR-
a/(3+ in LEC rats. In WKAH rats, 95.4 ± 3.1% of the
CD8+ lymph node cells were CD3+, and 78.0 ± 9.0%
were TCRa/J3+ . This may indicate that the proportion of
Thymocytes were stained by the two-color staining method as described in Materials and Methods. Spleen, lymph node, and peripheral blood cells
were stained separately with FITC-labeled anti-CD4 or anti-CD8 mAb as described in Materials andMethods. Analyses were performed with FAC-
Scan, and the percents of positive cells were estimated using a Consort 30 software program. Data represent the mean t SEM of observations ob-
tained from 4-20 rats.
p < 0.001 vs. WKAH.
t 0.001 < P < 0.005 vs WKAH .
5 0.025 < P < 0.05 vs. WKAH .
Table 1 . The Percent of T Cell Subsets in Various Organs in WK-4H, LEC and (WKAH x LEC) Fl Rats
CD4-8-
Thymus
CD4+8- CD4- 8+ CD4+8+
Spleen
CD4+ CD8+
Lymph node
CD4+ CD8+
Blood
CD4+ CD8+
WKAH
LEC
F1
3.6±0.4
5 .1±0.6
4.9±0.4
14.8±2.3 5.6±0.6
0.9±0.1'6.1±0.6
15.1±0.4 4.5±0.4
76.0±2.5
88.0t0.7"
75.6±0.7
24.4**-3.1
4.5±0.5'
21 .1±2.3
10.5±2 .1
9.0±1.9
14.2±3 .2
49.4±3 .4 17.7±2 .1
19.4±0.9"31 .4±2.Ot
53.0±1 .2 21.6±1 .7
39.3±1 .2
3.5±0.2'
34.0±1 .9
10.6±0.6
7.4±1 .15
12.6±1.4WKAH
￿
LEC
TCR-y/6+ cells in the CD8+ lymph node cells is greater
in LEC rats than that in WKAH rats, but it is unknown
whether this is related to deficiency in CD4+ T cells in LEC
rats. However, the important observation is that most of the
CD8+ cells express TCR/CD3 antigens. This was strength-
ened by the CTL assays of LEC lymph node cells (Fig. 5).
When LEC lymph node cells were incubated with spleen
cells from ACI rats (RT1') in vitro in the presence of exog-
enous IIr2, their cytolytic activities showed the same level
as those of LEA rat lymph node cells, which have the same
MHC haplotype as LEC rats (RT1°). This result indicates
that CD8+ cells in LEC lymph nodes have a normally func-
tional potential, in spite of the impaired CD4+ T cells.
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WKAH
￿
LE C
CD3
Figure 2.
￿
Expression of TCR (A) and CD3 (B) antigens on each subset of thymocytes in WKAH and LEC rats. Thymocytes stained with three
colors were first analyzed with a FACScan using two parameters, FLl (anti-CD4) and FL2 (anti-CD8), and then 13,000 cells of each subset were
collected using a live gate. Collected cells were analyzed by a parameter of FL3 (either antiTCR or anti-C133). The dotted line represents the profile
of cells stained without either antiTCR or anti-CD3 mAb. Results are representative of those obtained for three to four rats.
Dysfunction ofTh Cells.
￿
Deficiencies in the productions
of both IIr2 and ID4 were consequently observed in LEC
rats (Fig. 6, A and B). When spleen cellsfrom WKAH rats
were stimulated by either Con A or PWM, the supernatant
from the spleen cells supported the proliferation of CTLIr2
cells, whereas, the supernatant from the spleen cells of LEC
rats had a much lower ability to support their proliferation.
Thesedata indicate that the supernatant from the spleen cells
of WKAH rats contained appreciable 11,2, whereas that of
LEC rats did not. Stimulation of the lymph node cellswith
Con A and PWM revealed the difference between LEC and
WKAH rats more clearly (Fig. 6 A, rightpane; the super-
natant from control lymph node cells supported the prolifer-Figure 3.
￿
Expression ofclass IIMHC antigen in the thymus . Sections were stained with hematoxylin and eosin (A and B, x19.8) . Adjacent sections
were stained for class II MHC immunohistochernically (C and D, x300) . (A and C) Normal (VVKAH) rat ; (B and D) LEC rat . C and M indicate
the cortex and medulla, respectively. Note that class II antigens are expressed well in both the cortex and medulla of both strains .
Figure 4 .
￿
Expression ofTCR/CD3 an-
tigens onCD8* lymph node cells. Lymph
node cells stained with three colors were
first analyzed with a FACScan using two
parameters, FLi (anti-CD4) and FL2 (anti-
C138), and then 13,000 cells ofCD8 single-
positive subset were collected using a live
gate. Collected cells were analyzedby a pa-
rameter of FL3 (either antiTCR or anti-
CD3). (A and B)VVKAH rat; (C and D)
LEC rat . The dotted line represents the
profile ofcells stained without either anti-
TCR or anti-CD3 mAb. Results are rep
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￿
CTL assays in lymph nodecells ofLEC and LEA rats. Lymph
node cells fromLEC or LEA rats as responder cells were cocultured with
mitomycin C-treated ACI spleen cells as stimulator cells for 5 d in the
absence (open columns) or presence (10% fvol/voll) (filled columns) of the
supernatant of rat Con A blast spleen cells. Cells were harvested and in-
cubated with S'Cr-labeled target cells (ACI Con A blast spleen cells) for
15 h at 37°C . Released s 1Cr was counted, and values are expressed as
specific killing calculatedby the equation given in Materials and Methods.
Columns and bars represent means and SEMs of triplicated CTL assays.
ation ofCTLL2 cells, whereas that from LEC lymph node
cells did not at all. With respect to IL4, to which CTLIr2
cells responded weakly, we directly compared the mRNA
levels for 11,4 in spleen cells ofWKAH and LEC rats (Fig.
6 B) . Spleen cells from WKAH rats expressed mRNA for
IL4when stimulated by either mitogen, whereas spleen cells
fromLEC rats scarcely expressed thismRNA . The deficien-
cies in the productions of IL2 and 114 support the conclu-
sion that LEC rats have virtually no CD4+ cells, rather than
indicating alteration of the antigenic epitopes in their CD4
molecules .
It is ofinterest to compare the results of IL assays andFACS
analyses of the lymph node cells from LEC rats. The CD4+
cells (ti20%) in the lymph nodes can be considered to have
developed extrathymically, since CD4 single-positive cellsdo
not exist in the thymus ofLEC rats. The results suggest that
CD4-bearing cells that developed extrathymically do not func-
tion as Th cells. The organ that induces expression ofCD4
antigen on lymph node cells to supplement for the insufficiency
of the thymus is unknown .
From both physical and functional deficiencies inTh cells,
LEC rats were expected to be unresponsive to T cell-depen-
dent antigens. In fact, LEC rats did not produce antibodies
against SRBC, aT cell-dependent antigen (32), but produced
antibodies against DNP-conjugated Ficoll, a T cell-indepen-
dent antigen (33), as well asWKAH rats (Fig. 6 C) . Spleen
cells from LEC rats produced antibodies against DNP-
conjugated Ficoll without immunization more efficiently than
spleen cells from WKAH rats. However, the ratio of the
plaque-forming cells in immunized andnonimmunized rats
were almost consistent betweenLEC andWKAH rats. These
results indicate that Th cells are defective in helping the anti-
body production, but B cells produce antibodies normally
in LEC rats .
The origin of the mutation inLEC rats isunknown. CD4
antigen molecules, in spite of normal expression ofantigenic
epitopes, may be defective and so can not interact with class
IIMHC molecules or can not adequately transfer the signals
into intracellular elements. Another possibility is that there
is a defect in the TCR, such as the lack of the interaction
with class II MHC molecule or of the signal transduction .
A third possibility is a defect in production orrelease ofputative
thymic factors by stromal cells. To obtain further immuno-
logical information on this novel mutation, we have started
to make a congenic strain ofWKAH rats bearing only the
recessive gene, thid (Th immunodeficiency) . Through studies
of this rat at a molecular level, we hope that the molecular
mechanism of positive selection may be elucidated.
Recently, an interestinghuman case of immunodeficiency
was reported (34) . Although this patient showed maturational
arrest in the transition pathway from CD4+8+ to CD4 - 8+
cells, the similarity is very interesting between this patient
and LEC rats . As further investigations in humans develop,
the findings of such immunodeficient patients may increase.
LEC rats may become useful as an animal model for such
a genetic immunodeficiency in humans .
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Kruisbeek, N . Shinohara, and J. Meligeni for critical review of the manuscript; and Ms . K. Morita for
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￿
Deficiency in Th cell function in LEC rats. The supernatant from spleen and lymph node cells stimulated by either Con A (circles) or
PWM (triangles) was tested for ability to support growth of CTLI*2 cells (A) . Filled and open symbols represent data from WKAH and LEC rats,
respectively. Murine rIL2 (x) and rI1r4 (+) was used as a positive control. Results are representative of those obtained in three independent experiments
on spleen cells and two independent experiments on lymph node cells . The expression ofmRNA for I1r4 was examined simulataneously in the extracts
of the spleen cells (B). (Lanes 1 and 2) WKAH rat ; (lanes 3 and 4) LEC rat ; (lanes 1 and 3) stimulation by Con A ; (lanes 2 and 4) stimulation by
PWM . (C) Plaque-forming assay in spleen cells from normal (WKAH) and LEC rats immunized with either SRBC or DNP-conjugated Ficoll. The
basal levels of plaque formation by spleen cells from nonimmunized rats are shown by vertically striped columns. Columns and bars represent means
*_ SEMs of values for three rats. The results are representative of those in two experiments .
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